Oxford Instruments (OXINF) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Oxford Instruments Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.318 -- 00:00:05.184 Okay, good morning everyone and thanks for joining us here in the room and online for 00:00:05.184 -- 00:00:08.025 our half year results presentation. 00:00:08.068 -- 00:00:12.671 With me this morning is the familiar face of our CFO, Gavin Hill. 00:00:12.954 -- 00:00:17.580 So these results are good and they would have been even better but for some weakness 00:00:17.580 -- 00:00:20.463 in the healthcare and life sciences market. 00:00:20.463 -- 00:00:25.495 The order book remains strong, giving us good visibility into the second half 00:00:25.495 -- 00:00:30.624 we've made real inroads into our strategic priorities to improve, rebalance, 00:00:30.624 -- 00:00:32.968 and simplify the business. 00:00:32.968 -- 00:00:37.457 And all of this reinforces our confidence that we can improve returns from the business 00:00:37.457 -- 00:00:41.724 in the medium term as we articulated in June. 00:00:41.724 -- 00:00:44.209 More on that later. 00:00:44.209 -- 00:00:48.156 Gavin will be taking you through the detail of the results, but first, some highlights 00:00:48.156 -- 00:00:50.316 from me. 00:00:51.905 -- 00:00:57.132 It was a good first half performance with 10.4% revenue growth coming from both 00:00:57.132 -- 00:01:02.840 divisions supported by our market leading differentiated technology. 00:01:02.840 -- 00:01:08.566 And just to be clear, all the numbers on this slide are at constant currency. 00:01:09.450 -- 00:01:13.515 The performance has been driven by stronger growth in the market for new materials and 00:01:13.515 -- 00:01:16.139 even stronger growth in semiconductor, 00:01:16.139 -- 00:01:20.542 which more than offset the software healthcare and life science market. 00:01:21.082 -- 00:01:24.509 Operating profit at group level is a...